Silencing NIK potentiates anti-VEGF therapy in a novel 3D model of colorectal cancer angiogenesis.

about

Silencing NIK potentiates anti-VEGF therapy in a novel 3D model of colorectal cancer angiogenesis.

Item

http://www.wikidata.org/entity/Q55502779

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Silencing NIK potentiates anti ...... olorectal cancer angiogenesis.

@en

Silencing NIK potentiates anti ...... olorectal cancer angiogenesis.

@nl

type

Item

label

Silencing NIK potentiates anti ...... olorectal cancer angiogenesis.

@en

Silencing NIK potentiates anti ...... olorectal cancer angiogenesis.

@nl

prefLabel

Silencing NIK potentiates anti ...... olorectal cancer angiogenesis.

@en

Silencing NIK potentiates anti ...... olorectal cancer angiogenesis.

@nl

P1476

Silencing NIK potentiates anti ...... olorectal cancer angiogenesis.

@en

P2093

Anne Steins

http://www.w3.org/2001/XMLSchema#string

Boy Helder

http://www.w3.org/2001/XMLSchema#string

Chrissta X Maracle

http://www.w3.org/2001/XMLSchema#string

Hanneke W M van Laarhoven

http://www.w3.org/2001/XMLSchema#string

Kim C M Jeucken

http://www.w3.org/2001/XMLSchema#string

Sander W Tas

http://www.w3.org/2001/XMLSchema#string

Thomas M van Gulik

http://www.w3.org/2001/XMLSchema#string

P2860

Modes of resistance to anti-angiogenic therapy

Biomarkers of Angiogenesis in Colorectal Cancer

A heterogeneous in vitro three dimensional model of tumour-stroma interactions regulating sprouting angiogenesis

Nuclear factor-kappaB in cancer development and progression

Role of angiogenesis in tumor growth and metastasis

NF-kappaB in cancer: from innocent bystander to major culprit

Proteomics. Tissue-based map of the human proteome

Inflammation meets cancer, with NF-κB as the matchmaker

ZEB2 promotes tumor metastasis and correlates with poor prognosis of human colorectal cancer.

Expression of LIGHT/TNFSF14 combined with vaccination against human papillomavirus Type 16 E7 induces significant tumor regression

P304

28445-28455

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.25442

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29983872

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

6033358

http://www.w3.org/2001/XMLSchema#string